Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prophylactic ondansetron plus phenylephrine for spinal hypotension in obese cesarean section patients
TCTR20250427011Phase 4Completed
- Sponsor
- Chaophrayayommarat Hospital
- Start
- May 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of ondansetron and phenylephrine in obesity, pregnancy and intraoperative hypotension (IOH) (3 arms), sponsored by Chaophrayayommarat Hospital. Primary endpoint: Incidence of spinal anesthesia-induced hypotension. Started May 2025; status: completed.
02
Drugs
ondansetronphenylephrine
03
Conditions
obesitypregnancyintraoperative hypotension (IOH)
Beyond the preview
Go deeper on TCTR20250427011.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20250427011.